Meeting
2022 ASCO Annual Meeting
Non-invasive detection of esophageal carcinoma by integrative analysis of low-pass whole methylome sequencing of plasma cell-free DNA.
Authors
Dan Liu
Genecast Biotechnology Co., Ltd., Beijing, China
Dan Liu , Bin Jiang , Weizhi Chen , Peiyao Nie , Hongyu Xie , Tiancheng Han , Shunli Yang , Yu S. Huang , Fang Lv , Shuying He , Ying Yang , Yulong LI , Yuanyuan Hong , Jianing Yu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4067)
DOI
10.1200/JCO.2022.40.16_suppl.4067
Abstract #
4067
Poster Bd #
55
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Early detection of colorectal adenocarcinoma by decoding epigenetic and DNA fragmentation fingerprints of plasma cell-free DNA.
First Author: Li Suxing
Poster
2021 ASCO Annual Meeting
Detection of cancer signal for over 50 AJCC cancer types with a multi-cancer early-detection test.
First Author: Habte Aragaw Yimer
Poster
2024 ASCO Breakthrough
Analysis of heterochromatin remodeling as a mechanism of radiotherapy (RT) resistance through molecular profiling of radioresistant (RR) head and neck (HNC) and prostate cancers (PCa).
First Author: Evelyn Tan
Poster
2024 ASCO Annual Meeting
Leveraging cfDNA fragmentomic features in a stacked ensemble model for early detection of esophageal squamous cell carcinoma.
First Author: Zichen Jiao